Besides, zinc emerges as a novel inhibitor of Calcific aortic valve disease (CAVD).498 The ZnR/GPR39 is reduced in calcified aortic valves from patients with CAVD. Here, GPR39 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.